Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - New York Stock Exchange, Inc. - FR0013467479 - Common Stock - Currency: USD

14.4  -0.22 (-1.5%)

After market: 14.4 0 (0%)

Fundamental Rating

4

Overall CSTM gets a fundamental rating of 4 out of 10. We evaluated CSTM against 156 industry peers in the Metals & Mining industry. CSTM has a medium profitability rating, but doesn't score so well on its financial health evaluation. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CSTM was profitable.
In the past year CSTM had a positive cash flow from operations.
CSTM had positive earnings in 4 of the past 5 years.
In the past 5 years CSTM always reported a positive cash flow from operatings.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CSTM's Return On Assets of 2.44% is fine compared to the rest of the industry. CSTM outperforms 63.46% of its industry peers.
CSTM has a Return On Equity of 16.83%. This is amongst the best in the industry. CSTM outperforms 89.10% of its industry peers.
With an excellent Return On Invested Capital value of 11.15%, CSTM belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CSTM is below the industry average of 12.76%.
The 3 year average ROIC (8.33%) for CSTM is below the current ROIC(11.15%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROIC 11.15%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

CSTM has a Profit Margin (0.99%) which is comparable to the rest of the industry.
CSTM's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 3.72%, CSTM perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
CSTM's Operating Margin has declined in the last couple of years.
CSTM has a Gross Margin (12.18%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CSTM has grown nicely.
Industry RankSector Rank
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

2

2. Health

2.1 Basic Checks

CSTM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CSTM has been reduced compared to 1 year ago.
CSTM has more shares outstanding than it did 5 years ago.
CSTM has a worse debt/assets ratio than last year.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CSTM has an Altman-Z score of 3.21. This indicates that CSTM is financially healthy and has little risk of bankruptcy at the moment.
CSTM has a Altman-Z score of 3.21. This is comparable to the rest of the industry: CSTM outperforms 59.62% of its industry peers.
CSTM has a Debt/Equity ratio of 2.53. This is a high value indicating a heavy dependency on external financing.
CSTM has a Debt to Equity ratio of 2.53. This is amonst the worse of the industry: CSTM underperforms 91.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Altman-Z 3.21
ROIC/WACC1.25
WACC8.93%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.23 indicates that CSTM should not have too much problems paying its short term obligations.
CSTM has a Current ratio of 1.23. This is in the lower half of the industry: CSTM underperforms 76.92% of its industry peers.
A Quick Ratio of 0.53 indicates that CSTM may have some problems paying its short term obligations.
CSTM has a Quick ratio of 0.53. This is amonst the worse of the industry: CSTM underperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

CSTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.49%.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
Looking at the last year, CSTM shows a very strong growth in Revenue. The Revenue has grown by 80.43%.
Measured over the past years, CSTM shows a small growth in Revenue. The Revenue has been growing by 4.43% on average per year.
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%

3.2 Future

The Earnings Per Share is expected to grow by 69.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, CSTM will show a quite strong growth in Revenue. The Revenue will grow by 12.37% on average per year.
EPS Next Y150.49%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue Next Year13.42%
Revenue Next 2Y10.91%
Revenue Next 3Y12.37%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.66 indicates a quite expensive valuation of CSTM.
CSTM's Price/Earnings is on the same level as the industry average.
CSTM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.86.
CSTM is valuated reasonably with a Price/Forward Earnings ratio of 8.90.
CSTM's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSTM is cheaper than 83.97% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (34.94), we can say CSTM is valued rather cheaply.
Industry RankSector Rank
PE 49.66
Fwd PE 8.9
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSTM indicates a rather cheap valuation: CSTM is cheaper than 90.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.06
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CSTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CSTM may justify a higher PE ratio.
A more expensive valuation may be justified as CSTM's earnings are expected to grow with 69.72% in the coming years.
PEG (NY)0.33
PEG (5Y)15.21
EPS Next 2Y98.45%
EPS Next 3Y69.72%

0

5. Dividend

5.1 Amount

No dividends for CSTM!.
Industry RankSector Rank
Dividend Yield N/A

CONSTELLIUM SE

NYSE:CSTM (8/20/2025, 8:04:01 PM)

After market: 14.4 0 (0%)

14.4

-0.22 (-1.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners92.96%
Inst Owner Change-0.06%
Ins Owners1.78%
Ins Owner ChangeN/A
Market Cap2.11B
Analysts82.22
Price Target19.38 (34.58%)
Short Float %2.64%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)129.83%
Min EPS beat(2)-17.42%
Max EPS beat(2)277.07%
EPS beat(4)1
Avg EPS beat(4)-188.59%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-110.02%
EPS beat(12)3
Avg EPS beat(12)-76.02%
EPS beat(16)5
Avg EPS beat(16)-28.44%
Revenue beat(2)1
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-5.83%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.56%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)4
Avg Revenue beat(12)-1.8%
Revenue beat(16)8
Avg Revenue beat(16)0.42%
PT rev (1m)10.14%
PT rev (3m)10.14%
EPS NQ rev (1m)14.54%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)0%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)9.92%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 49.66
Fwd PE 8.9
P/S 0.16
P/FCF N/A
P/OCF 8.87
P/B 2.71
P/tB 3.3
EV/EBITDA 5.06
EPS(TTM)0.29
EY2.01%
EPS(NY)1.62
Fwd EY11.24%
FCF(TTM)-1.05
FCFYN/A
OCF(TTM)1.62
OCFY11.28%
SpS90.29
BVpS5.31
TBVpS4.36
PEG (NY)0.33
PEG (5Y)15.21
Profitability
Industry RankSector Rank
ROA 2.44%
ROE 16.83%
ROCE 14.12%
ROIC 11.15%
ROICexc 11.59%
ROICexgc 12.1%
OM 3.72%
PM (TTM) 0.99%
GM 12.18%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Debt/EBITDA 2.49
Cap/Depr 131.4%
Cap/Sales 2.96%
Interest Coverage 6
Cash Conversion 30.1%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.53
Altman-Z 3.21
F-Score7
WACC8.93%
ROIC/WACC1.25
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.49%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%-53.96%
EPS Next Y150.49%
EPS Next 2Y98.45%
EPS Next 3Y69.72%
EPS Next 5YN/A
Revenue 1Y (TTM)80.43%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%3.35%
Revenue Next Year13.42%
Revenue Next 2Y10.91%
Revenue Next 3Y12.37%
Revenue Next 5YN/A
EBIT growth 1Y29.69%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year108.99%
EBIT Next 3Y38.47%
EBIT Next 5YN/A
FCF growth 1Y-224.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.65%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%